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Abstract 
Background: Blunt and penetrating traumatic thoracic aortic injuries constitute surgical 
emergencies that are attended with high mortality rates. Most patients do not survive long enough, 
post injury, to reach a hospital. On-site mortality rates may approach approximately 85%. Two 
main treatment options for blunt thoracic aortic injuries (BTAI) are open surgery and thoracic 
endovascular repair (TEVAR). Penetrating thoracic aortic injuries (PTAI) have a higher mortality 
than blunt trauma, with patients often only reaching the hospital in extremis. Most will require 
early intervention. Currently TEVAR is rapidly evolving as the standard of care for thoracic aortic 
injuries (TAI) at many centres, primarily due to the emerging evidence of lower mortality and 
morbidity trends in comparison to open surgery (1–4). 
Methods: From December 2006 to December 2016, 34 patients (30 blunt trauma, 4 penetrating 
trauma) with traumatic aortic injuries (grades I-IV) were treated with thoracic aortic stent-grafts in 
the Groote Schuur Hospital Vascular Unit, Cape Town. We assessed the technical and clinical 
outcomes following TEVAR in these patients. 
Results: The 30- day mortality rate was 5.8%, corresponding to 2 deaths both associated with the 
index trauma-related fatal strokes. The overall mortality rate was 11.8% (4/34): three deaths were 
due to major strokes and one death was related to pulmonary complications. 
Conclusion: TEVAR after TAI is associated with significantly lower procedural and post- 
operative mortality. The 30 day and overall mortality after TEVAR in our unit is comparable to 
international standards. Even though there is a paucity of literature on PTAI, TEVAR has low peri- 
procedural adverse events and is safe in selected patients. 
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Chapter 1 
1.0 Introduction 
Blunt traumatic thoracic aortic injury (BTAI) caused by motor vehicle accidents and less 
commonly by other blunt thoracic trauma, constitutes a surgical emergency that is often attended 
with high mortality rates. Most patients die at the scene of the trauma. Two main treatment options 
for BTAI are open surgical repair (OSR) and thoracic endovascular repair (TEVAR). Penetrating 
thoracic aortic injuries (PTAI) generally have a higher mortality than blunt trauma, with patients 
reaching the hospital often in extremis. On-site mortality in both these cases approach 85%. 
Currently TEVAR is rapidly evolving as the standard of care for thoracic aortic injuries (TAI) at 
many centers, primarily due to the publication of consistent evidence of lower mortality and 
morbidity rates when compared to open surgery (1–4). We only started performing TEVAR at 
Groote Schuur Hospital (GSH) since 2006. 
1.1 Background and Literature Review 
1.1.1 Trauma in South Africa 
The burden of civilian trauma in South Africa is absolutely devastating (5). In 2007 the National 
Injury Mortality Surveillance System recorded 33 484 civilian trauma-related deaths, more than 
one-third of which were related to inter-personal violence, followed by traffic injuries (6). Thoracic 
aortic injury statistics are lacking in this part of the world mainly due to high pre-hospital mortality 
rates associated with this condition. Only a relatively few patients survive to an adequately 
equipped hospital, and even less will make it to the operating theatre. 
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1.1.2 Blunt thoracic aortic injuries (BTAI) 
The first-reported case of BTAI was by the Italian anatomist Andreas Vesalius in 1557 (7), who 
identified aortic rupture as the cause of death in a patient thrown from a horse. Now with the 
availability of modern imaging technologies, BTAI, a life-threatening surgical emergency is more 
easily diagnosed and, untreated, is generally associated with a high mortality. The mechanism of 
injury is related to sudden horizontal or vertical acceleration-deceleration injury, and most cases 
are a result of motor vehicle accidents (MVA), pedestrians struck by vehicles (PVA), or falls (1– 
3). 
1.1.3 Penetrating aortic injuries (PTAI) 
Penetrating aortic injuries have an exceptionally high mortality rate with no improvement in 
survival despite improved trauma services. Regarding PTAI, gunshot wounds, un-recordable blood 
pressure on admission, and the need for emergency room thoracotomy, are important predictors of 
high mortality (8). 
1.1.4 Open Surgical Repair 
Thoracic endovascular aortic repair (TEVAR) has evolved since the introduction of open surgical 
repair in 1959 (7), with the first description of TEVAR by Volodos in 1991. (9) Open repair has 
been shown to be associated with a high peri-operative mortality and morbidity rate (3,4). The 
AAST-1 trial evaluated outcomes after open repair. The study reported that the mean time from 
trauma centre admission to thoracotomy was 15 hours. Most repairs in this study were performed 
using cardiac bypass support. Paraplegia occurred in 9% of patients. The peri-operative and overall 
mortality rates were 15 and 31 %, respectively (10) 
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1.1.5 Thoracic endovascular aortic repair (TEVAR) 
Thoracic endovascular aortic repair (TEVAR) was a transformative advance in the treatment of 
BTAI and was first described for management of aortic injury in conventional practice by Michael 
Dake and colleagues in 1997 (11). We now appreciate that TEVAR offers several advantages, 
including minimally invasive peripheral access obviating a thoracotomy and single-lung 
ventilation, avoidance of aortic cross-clamping, avoidance of procedural anti-coagulation in critical 
cases (the vast majority), and avoidance of opening into the mediastinal hematoma (2). In 2008 the 
AAST-2 study was published. TEVAR was associated with significantly lower procedural and 
post-operative morbidity and mortality rates compared to open surgical repair (12). The RESCUE 
trial was a prospective, non-randomized, multi-centre device trial that enrolled 50 patients with 
BTAI and reported one year follow-up data. Major procedural and long-term device-related 
complications were infrequent, and no patients required aortic re-intervention or had neurologic 
complications. Of the 20 patients who had coverage of the left subclavian artery, only three (15 %) 
required revascularization. Overall mortality at 30 days and at 1 year was 8 and 12 %, respectively; 
two deaths (4 %) were adjudicated as aortic-related (13). TEVAR allows rapid and effective 
therapy in trauma patients with blunt aortic injury. The outcome is dependent on the severity of 
the concomitant injuries. The treatment is durable during the first decade after the procedure, but 
even longer follow up is needed to determine the impact of TEVAR in young patients on the 
degenerative changes that take place in the aging aorta.(14)  
1.1.6 The paradigm shift 
Comparison between the two AAST studies in 1997 and 2007 showed a major shift in the diagnosis 
of the aortic injury, with the widespread use of CT scan and the almost complete elimination of 
Page | 4 
aortography and TEE. The concept of delayed definitive repair has gained wide acceptance. This 
provides a window of opportunity to attend to critical issues and interventions, and more 
importantly to prognosticate before aortic repair. Endovascular repair has virtually replaced open 
repair. These paradigm shift has not only resulted in a major reduction in mortality 
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and procedure-related paraplegia, but is also associated with a significant decrease of early 
stentgraft-related complications (15). A Metaanalysis of publications with open and stent-graft 
repair cohorts was performed by Hoffer et al. to evaluate whether there was a difference in 
treatment effect with regard to mortality and paraplegia. Nineteen publications that compared the 
outcomes of 262 endograft repairs and 376 open surgical repairs were identified. The data 
support stent-graft repair as a highly successful technique that may reduce mortality and 
paraplegia rates by half compared with open surgery and supports endograft repair as first-line 
therapy for blunt thoracic aortic trauma.(16)  The evolution of stentgraft design over time has 
resulted in more conformable devices that are better equipped to accommodate severely 
angulated aortic arches, especially in young patients. Consequently, stentgraft compression seen 
with earlier devices are less frequently reported nowadays. 
1.1.6 Indications for TEVAR 
A classification scheme for grading the severity of aortic injury has been proposed: type I (intimal 
tear), type II (intramural hematoma or intimal flap), type III (pseudo aneurysm), and type IV 
(rupture) (17). The Society for Vascular Surgery (SVS) 2011 guidelines recommends expectant 
management with serial imaging for type I injuries, while types II to IV should be repaired. With 
the advent of high-resolution helical CT scanning for the diagnosis of suspected BTAI, 
identification of minimal aortic lesions has become increasingly prevalent. Approximately 10% of 
patients with BTAI experience minimal aortic injuries that result in focal intimal tears with no or 
little involvement of the media (18). However, 21% of BTAI patients with minimal aortic injuries 
undergo TEVAR despite the clinical practice guidelines of the Society of Vascular Surgery to the 
contrary (19). 
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1.2 Purpose and study justification 
Several studies have shown favourable results after TEVAR for blunt thoracic aortic injury 
(BTAI). Here we report our 10-year experience with TEVAR for traumatic thoracic aortic injuries 
(TTAIs). There has been paucity of literature on TEVAR after penetrating thoracic aortic injury 
(PTAI). We believe that this study could produce data and stimulate further research that may be 
of real benefit 
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to patients including long term outcomes, durability of stent grafts, and the use of stent grafts in 
the younger population, CT angiography surveillance and exposure to radiation. 
1.3 Hypothesis 
Our hypothesis is that TEVAR after TAI is associated with significantly lower procedural and post- 
operative morbidity and mortality. We postulated that the 30-day mortality after TEVAR, despite 
resource limitations in an African setting, will be comparable to international standards 
1.4 Research aim and objectives  
The study specific objectives are to assess the technical and clinical outcomes following TEVAR 
in patients with civilian trauma-related TAIs (TTAI) 
Outcome measures 
➢ Primary outcomes
o 30 day and overall mortality
➢ Secondary outcomes
o Procedure-related morbidity (paraplegia, cerebrovascular accident, conversion to
open repair)
o Systemic complications (acute renal failure; pulmonary complications; etc.)
o Device-related complications (stent configuration and wall apposition-arch, stent
fracture, stent migration, endo-leak; stent-graft sepsis and retrograde dissection)
o Re- intervention rates
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Chapter Two 
Methodology 
2.1 Study Design and Population 
Single centre retrospective descriptive study of all patients treated by the Vascular Unit at Groote 
Schuur Hospital. 
2.2 Study Setting 
This study was conducted at Groote Schuur Hospital in Cape Town, South Africa. Groote Schuur 
Hospital is a tertiary referral hospital and currently the main Teaching Hospital for the University 
of Cape Town, Faculty of Health Sciences. It serves patients from Cape Town and its catchment 
areas in Western Cape Province. 
2.3 Inclusion and Exclusion Criteria 
We included all patients aged over 18 years who were admitted to our Vascular/Trauma units with 
TTAI confirmed on CT scan on admission who were treated with TEVAR from December 2006 
to December 2016. 
2.4 Baseline Characteristics 
Patients were assigned a study number. Baseline demographic and clinical characteristics, imaging 
and treatment data were extracted from trauma registry, vascular registry and theatre registry. 
2.5 Injury circumstances 
Mechanism of injury was recorded as blunt or penetrating. Information relating to whether safety 
belts (restrained) or helmets for motorcyclists were used was also obtained from the pre-hospital 
and trauma registry. Civilian injury circumstances recorded were either motor vehicle accidents 
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(MVAs), pedestrian vehicle accidents (PVAs), falls, motorcycle, gunshot wounds (GSW) or stab 
wounds. 
2.6 Clinical Measurements 
Patients’ hemodynamic status on arrival to the hospital (systolic blood pressure, the need for 
inotropic support or ventilator support) was recorded. The severity of head injury was recorded as 
the Glasgow Coma Scale (GCS). The Injury Severity Score, an anatomical scoring system that 
provides an overall score for patients with multiple injuries, was calculated for each patient. Each 
injury was assigned an Abbreviated Injury Scale (AIS) score and was allocated to one of six body 
regions (Head, Face, Chest, Abdomen, Extremities (including Pelvis), and External). Only the 
highest AIS score in each body region was used. The 3 most severely injured body regions have 
their score squared and added together to produce the ISS score (20). 
2.7 Laboratory Measurements 
The Hemoglobin (Hb), Creatinine and HIV status, was obtained from the National Laboratory 
Health System (NHLS) database. An Arterial Blood Gas (ABG) recording pH and lactate was also 
recorded. 
2.8 Imaging 
A chest X-ray (CXR) was performed on all patients. For patients seen before 2012 a documentation 
of x-ray findings was extracted from the trauma registry. Patients seen in 2012 and thereafter, all 
CXR images were available on i-SITE for review. A Widened mediastinum was defined as a 
measured width of >8 cm, a mediastinal-chest width ratio of >0.38 (measured at the level of the 
aortic arch), or simply the physician's impression that the mediastinum is widened (20). A 
computed tomographic angiogram (CTA) was performed on all patients with suspected thoracic 
aortic injuries or for other trauma indications. These were reviewed and the aortic injuries were 
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severity-graded according to recommended classification systems accordingly: type I (intimal 
tear), type II (intramural hematoma or intimal flap), type III (pseudo aneurysm), or type IV 
(rupture) (21). Intra-operatively an angiogram was performed and the reported findings were 
obtained from the operative notes and recorded vascular C-arm images, captured in theatre. The 
type of aortic injury was noted. The arch type was recorded, measured as the vertical distance from 
the origin of the innominate artery to the top of the arch, type 1(distance < 1 common carotid 
diameter (CCA), type 2(between 1 and 2 CCA diameters) and type 3 (> 2 CCA diameters) (22). 
Arch anomalies were also identified and recorded. 
2.8 Intraoperative data 
The time from injury to surgery was deduced from the trauma admission and operative notes. The 
anesthetic notes were also perused to obtain information on the use of heparin, ASA classification 
and the total duration of surgery. The type and size of device used and the access vessels were also 
recorded. The proximal landing zones were recorded as; Zone 0- the ascending aorta proximal to 
the innominate artery; Zone 1- between the innominate and left common carotid artery; Zone 2 - 
between the left common carotid artery and the left subclavian artery; Zone 3 -descending thoracic 
aorta distal to the left subclavian artery; Zone 4 - the proximal descending thoracic aorta > 2cm 
distal to the left subclavian artery (15). Information regarding intentional coverage of the left 
subclavian artery (LSCA), embolization of the LSCA, hybrid procedures, or any additional 
vascular or non-vascular surgical procedures were obtained from the operative notes. Technical 
success was defined as complete aortic stentgraft coverage of the thoracic aortic lesion. 
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2.9 Follow up 
endo-leak or stentgraft sepsis). 
2.10 Search Methods 
A literature search of relevant literature was performed initially in August 2015 and repeated for 
new references in August 2016 and August 2017. The literature search was conducted using 
PubMed (MEDLINE), PubMed Central and the Medical Subject Headings (MeSH) databases. The 
following search headings or terms were used: “BTAI”, “TEVAR”, “penetrating thoracic injury”, 
“outcomes”, “procedure related”, “device related”, “mortality”, “paraplegia”, “follow up” and “late 
complications”. The search terms were used for all fields (including title, abstract, keywords and 
full text), and all results types were included. Further sources were identified by following up 
internal citations and references within the documents retrieved in the initial search. Due to the 
applied methodology, the review excluded research currently underway that is not available in 
certain databases, or studies which have not been published in English. 
2.11 Ethical Clearance 
Approval for this study was obtained from the Human Research Ethics Committee, Faculty of 
Health Sciences and University of Cape Town (REF: 635/2016). 
Data reporting on post-operative adverse events, the length of hospital stay and ICU stay were 
obtained from patients’ files. The CTAs were scheduled at 1 month, 6 months, 12 months and 
annually thereafter. Regular clinical reviews reported on symptomatology (left upper limb 
ischaemia, chest discomfort, chest pain, cerebrovascular symptoms) and imaging for device related 
complications (stent configuration and wall apposition-arch, stent fracture, stentgraft migration, 
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2.12 Budget and Justification 
The study did not need an extra budget as the results used were captured from hospital records by 




A total of 34 patients were enrolled into the study. There were 31 males (91.2%) and three (8.8%) 
females. The mean age of enrolled patients was 35.1 +/- 11.5 (Range: 20 – 65 years). Twenty-six 
patients had no medical comorbidities. Three patients were RVD positive. The following 
comorbidities were also identified: one HPT; one HPT/DM; one HPT/DM/RVD; one epileptic; one 
previous PTB with pneumonectomy and one schizophrenic. Nineteen patients did not know their 
HIV status, 12 were negative and three were positive. All three HIV positive patients were on 
treatment. Fourteen patients were smokers and 20 patients were non-smokers. None of the patients 
had previous aortic surgery (open or endovascular). The median GCS was 15 (Range: 4-15). 
Twenty-six patients were not intubated and eight were intubated either at the scene or on arrival at 
the hospital. Table 1 summarizes the baseline characteristics. 
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Table 1: Baseline characteristics 
Characteristics N=34 
Age 
Mean ± SD 
Median (range) 







ISS, median (range) 31 (13-66) 
Ventilation 8 























Previous aortic surgery 0 
3.1 Vital signs 
The pulse distribution is skewed to the right with the mean pulse rate of 112 ± 20/minute and mean 
systolic pressure of 116 ± 25mmHg. The systolic pressure distribution is normal and pulse 
distribution is skewed to the right as shown in figure 1 and 2 below. 
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Figure 1: SBP distribution Figure 2: Pulse distribution 
3.2 Biochemical variables 
The average pH of patients on admission was 7.38 ± 0.06; minimum recorded pH 7.23 and 
maximum pH 7.47. The frequency distribution of some biochemical variables (lactate, Hb, 
creatinine) are as shown in table 2. 
Table 2: frequency distribution of biochemical variables 
Ph Lactate Hb Creatinine 
N Valid 28 23 33 28 
Missing 6 11 1 6 
Mean 7.3829 1.7148 10.782 81.571 
Median 7.3900 1.1000 11.000 79.000 
Std. Deviation  .06024 1.86877 2.1809 29.8185 
Minimum 7.23 .10 6.6 34.0 
Maximum 7.47 9.00 15.0 167.0 
Hb (g/dl); creatinine (Umol/L); lactate (mmol/L) 
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3.3 Mechanism of Injury 
Thirty patients sustained blunt trauma and 4 patients sustained penetrating trauma. In the blunt 
trauma group, 28 patients sustained motor-vehicular accidents while 2 patients were involved in 
falls from a height. 
In the group of patients that sustained motor vehicular accidents (N=28): seven were unrestrained 
drivers, four were motorcyclist (two with helmets on and two with helmet use information not 
documented), eight were unrestrained passengers and nine were pedestrians. In the group of 
patients that sustained injuries due to penetrating trauma, three were related to gunshot wounds and 
one was an iatrogenic injury sustained at thoracotomy. Comparatively, penetrating trauma patients 
were younger with a median age of 28 (range 22-56) and had a median ISS of 17. No grade IV 
aortic injuries were documented for penetrating aortic injuries. Table 3 summarizes the comparison 
between blunt and penetrating trauma. 
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Table 3: Comparison between blunt and penetrating trauma 
Characteristics Blunt trauma (n=30) Penetrating trauma (N=4) 
Age, median (range) 35 (20-65) 28 (22-56) 
Gender 
Male 27 4 
ISS, median (range) 33 (13-66) 17 (16-34) 
Ventilation 8 0 
GCS, median (range) 15 (4-15) 15 (In all four patients) 
Comorbidities 2HPT/DM, 1HPT, 2Other 1PTB 
ICU stay, mean ± SD 8 (±7.0) 2 (±5) 
Renal failure 1 0 
Extent of aortic injury 
Grade I: intimal tear 
Grade II: intramural hematoma 
Grade III: pseudo-aneurysm 









Day of TEVAR, median (range) 2.0 (0-20) 13.5 (4-67) 







Secondary end points(overall) 
Procedure related 





Technical success 28/30 (93.3%) 4/4 (100.0%) 
Re-intervention rate 2/30 (6.7%) 0/4 (0.0%) 
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3.4 Imaging 
On chest x-ray imaging 22 patients had a widened mediastinum and 12 patients had a normal 
looking mediastinum. The commonest aortic pathology was a grade III aortic injury (64.7%) 
followed by grade II aortic injuries (23.5%). Only one patient (2.9%) had a grade I aortic injury 
and three patients (8.8%) had grade IV aortic injuries. We found that 82.4% of our study population 
had a Type 1 arch on CTA imaging. We found this to be very deceptive during catheter angiogram 
where young aortic arches were found to be more angulated than expected resulting in challenging 
deployment of the aortic stentgraft during TEVAR. Eighty-two percent (28/34) of our patients had 
a normal aortic arch and supra-aortic vessel configuration. The commonest arch anomaly was a 
bovine arch (5/34 patients). Two patients had a left vertebral artery arising from the aortic arch 
between the origins of the left CCA and the left SCA. One patient had a bovine anomaly associated 
with an aortic origin of the left vertebral artery. (Table 4) 
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Table 4: Injury proportions grouped according to different classification schemes 





Motor-Vehicular Accidents (MVA) 
Fall 











CLASSIFICATION SCHEME ACCORDING TO INJURY 
SEVERITY 
Grade I: intimal tear 1 2.9 
Grade II: intramural haematoma 8 23.5 
Grade III: pseudo-aneurysm 22 64.7 
Grade IV: free rupture 3 8.8 
ANATOMICAL RADIOLOGICAL CLASSIFICATION 
SCHEMES 
Arch Types 
Type 1 28 82.4 
Type 2 4 11.8 
Type 3 2 5.8 
Arch Anomalies 
Bovine arch 3 8.8 
Vertebral artery off the arch 2 5.9 
Bovine arch and left vertebral artery off the arch 1 2.9 
Extent of overall injuries 
Assigned ISS 
Mean ± SD 
Median (range) 
34.0 ± 14.9 
31(13-66) 
3.5 Time to TEVAR 
Our protocol consisted of initial stabilization, blood pressure control, anti-impulse therapy where 
appropriate and treatment of associated injuries followed by delayed repair. This allowed for other 
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life-threatening injuries to be addressed first. No patient died secondary to aortic rupture while 
awaiting a TEVAR. 
3.6 Procedure 
All TEVAR procedures were performed under general anaesthesia using a vascular C-arm in the 
operating room (OR). The average length of operation was 323 minutes (Range: 85 – 700 minutes). 
Access was generally obtained via the femoral approach (groin cut-down with a contra-lateral 
femoral access sheath for imaging). Systemic heparinization was used in 82.4% (28/34) of patients 
prior to the deployment of the stent graft. These patients did not have any compelling contra- 
indication to systemic anti-coagulation. The left subclavian artery was intentionally covered in 
47.0% of patients (16/34), with complete coverage in 23.5% (8/34). Only two (2/16), with 
intentional coverage of the LSCA had hypoplastic right vertebral arteries requiring LSCA 
revascularization. Four (4/16) had anomalous arch configuration, three with bovine arch and left 
vertebral artery coming off the arch and one with an isolated vertebral artery coming off the arch. 
None of these patients required revascularization. Two patients had a left carotid – LSCA bypass, 
both these patients had their left SCA intentionally covered. Three patients had a hybrid arch 
procedure: right common carotid- left common carotid bypass and a left common carotid-LSCA 
bypass. The proximal stump of the left CCA was ligated in these cases. Cases requiring a left CCA 
– LSCA bypass generally had an Amplatzer embolic plug deployed in the proximal LSCA close to
the aortic arch. 
Seventy percent (24/34) of the thoracic aortic devices were 26 mm or less in diameter. Thirty-two 
(94.1%) of the TEVAR procedures were technically successful. One patient had a small type II 
endo-leak via the left SCA. This was addressed immediately with a left SCA plug. One patient had 
an  inner  curve  mal-apposition  of  the  aortic  stentgraft  (bird-beaking).  Eight patients  had  an 
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additional vascular procedure. Table 5. The mean hospital stay was 23 ±14.5 days (Range: 7 – 65 
days). The mean ICU stay was 7 days (Range 0- 28 days) 
Table 5: Additional vascular procedures 
Procedure Left common carotid -LSCA 
bypass (N=2) 
Right CCA-left CCA + 




LSCA Intentionally covered both 
patients 
2 not covered 
1 intentionally covered 
3.7 Primary end points 
The 30- day mortality rate was 5.8% (2 patients), all related to fatal major strokes. One of these 
strokes was secondary to a blunt carotid dissection that was related to trauma. One patient had an 
uneventful early post-operative course but developed a fatal major stroke on day 15 post TEVAR. 
Non-of these strokes were related technically to the TEVAR procedure. The overall mortality rate 
was 11.8% (4/34): three deaths were secondary to fatal strokes and one death was secondary to 
pulmonary complications. 
Early deaths 
Patient #21: 30year old male. Previously healthy. Unrestrained MVA passenger. On arrival GCS- 
15/15, with an injury severity score (ISS) of 31. No focal neurological deficit. No carotid bruits. 
CXR – widening of mediastinum (figure 3). CTA- Pseudo-aneurysm (figure 4). TEVAR done on 
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Day 4 of admission. Access through the common femoral artery (CFA). LSCA not covered. With 
good technical success. Length of surgery 320mins. 
Post-operative course: 
 Day 1 in ICU- doing well with no immediate complications
 Day 2 -discharged from ICU
 Day 3- stable in the ward
 Day 4 – suffered a massive stroke and died.
Post mortem- blunt left carotid artery dissection with a fatal CVA. 
Figure 3: initial CXR showing widened mediastinum 
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(a) (b) 
(c) 
Figure 4 (a,b,c): CTA showing grade IV aortic injury (patient #21) 
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Figure 5: day 1 post TEVAR – stent graft in place (patient #21) 
Patient #14: 37-year-old male. Background of hypertension. MVA unrestrained passenger. On 
arrival GCS -15/15, ISS-29. Widened mediastinum on CXR. CTA showed anatomical class 3 aortic 
injury. TEVAR done day 5 of admission. Access through the common femoral artery (CFA). LSCA 
not covered. With good technical success. Length of surgery 270mins 
No available images 
Post-operative course was relatively unremarkable for a trauma patient. 
 Fatal CVA –day 15 (post mortem report not available)
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3.8 Secondary end points 
There was one recorded common femoral artery dissection. This was identified and repaired at the 
time of the TEVAR procedure. Six patients developed pneumonia. One patient developed renal 
failure requiring dialysis. Two patients developed groin wound infection. One patient developed 
a urinary tract infection. Three patients developed a stroke while in the intensive care unit. Two 
of the three were fatal strokes. One patient had a confirmed deep venous thrombosis. One patient 
developed a pulmonary embolism. One patient post TEVAR required a thoracotomy for evacuation 
of a massive mediastinal haematoma during the first 30 days. This patient had a persistent left main 
bronchus compression and failure to wean off the ventilator. 
Surveillance imaging was performed at 1 month; 6monthly then annually post-TEVAR and 
reviewed. One patient had “bird-beaking”, without stentgraft compression, after deployment which 
was managed expectantly. 
A total of 28 patients (82.36%) availed themselves for late follow-up. The average duration of 
follow-up was 25±23 months (Range: 12 – 96 months). Six patients were lost to follow-up. One 
patient presented a few months later with a saccular aneurysm at the proximal landing zone 
extending into the distal arch. This patient had significant crowding of the supra-aortic vessels. A 
hybrid arch procedure was performed, involving total arch debranching and translocation of the 
vessels to the ascending aorta with retrograde extension of the aortic stentgraft. The patient 
developed a major post –operative stroke and demised. Following this case, we currently routinely 
occlude the proximal LSCA with an Amplatzer plug when we revascularize the LSCA. 
No further device related complications (stent graft migration, oesophageal or mediastinal erosion, 
stentgraft sepsis, stentgraft collapse or compression, stent fractures, etc.) was documented on 
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follow-up in the remaining patients. Four patients died on late follow-up. Table 6 summarizes the 
study end points. 
Table 6: Study end points 





Secondary end points 
Early outcomes (30-day results) 
  Systemic complications 
(pneumonia 6; renal failure 1; 
wound sepsis 2;urinary tract 
infection 1; DVT 1; 
pulmonary embolism 1) 
  Procedure related 
      Technical success 
Late complications (>30-day results) 
Clinical outcomes 
Technical success 




1 arm claudication 
32/34 (94.1%) 
1 saccular aneurysm at proximal landing zone 
Re-operations 2/34 (5.8%) 
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Table 7: Comparison of survivors and non-survivors 
Characteristics Survivors (n=30) Non-survivors (N=4) 
Age, median (range) 34 (20-65) 32.5 (27-56) 
Gender 
Male 27 4 
ISS, median (range) 33 (13-66) 25 (16-31) 
Ventilation 7 1 
GCS, median (range) 15 (4-15) 15 (9-15) 
Comorbidities 2HPT/DM, 1PTB, 2Other 1HPT 
ICU stay, mean ± SD 7 (7.5) 6 (±6.9) 
Renal failure 0 1 
Day of TEVAR, median 
(range) 







Inner-curve mal-apposition of 
TEVAR device 
1 1 
stentgraft collapse / 
compression 
0 0 
Leg ischemia 0 0 
3.9 Neurologic outcomes 
Upon admission, none of our patients had neurologic deficit attributable to associated head injury. 
Four patients presented with trauma-related paraplegia, 3 of these patients had paraplegia 
secondary to spinal cord injury and one patient had established lumbosacral radiculopathy (HIV – 
related). No patient had a pre-interventional history of a stroke. There were no cases of spinal cord 
ischemia or strokes related to the TEVAR procedure. 
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Chapter Four 
4.0 Discussion 
Nearly twenty-five years ago, Volodos et al. (9) performed the first thoracic endovascular aortic 
repair (TEVAR). The same year Parodi et al. (23) performed the first endovascular aortic repair 
(EVAR). It was in 1999 when the U.S Food and Drug Administration (FDA) approved the use of 
endografts for abdominal aortic aneurysm repair and EVAR was rapidly adopted. However, it was 
not until 2005 when the FDA also approved the use of endografts for descending thoracic 
endovascular repair (TEVAR) 
Since the introduction of commercially available aortic stentgrafts, TEVAR has been increasingly 
used as a primary treatment option for BTAI. There is little doubt that TEVAR offers several 
advantages over open surgical repair, including minimally-invasive peripheral access obviating 
thoracotomy; avoidance of single-lung ventilation, avoidance of cardiac bypass and aortic cross- 
clamping and avoiding interfering with the mediastinal hematoma (3). In the 2008 AAST-2 study, 
TEVAR was associated with significantly lower procedural and post-operative morbidity and 
mortality compared to open repair (12). 
We retrospectively looked at the outcomes of TEVAR in TTAI (both blunt and penetrating) at a 
single center. Our 30-day all-cause mortality was 5.8%, better than the 8% reported in the RESCUE 
trial which was designed as a descriptive study focused on safety outcomes. The RESCUE trial 
prospectively investigated the outcomes of TEVAR in multiple centers using the Medtronic Valiant 
Captiva stent graft (Medtronic, Inc.) in patients with BTAI and reported a 30-day all-cause 
mortality of 8.0% and 12.0% at 1 year (13). It is noteworthy that the RESCUE trial investigators 
were selected from high volume centers experienced with TEVAR. Demetriades et.al reported a 
significant reduction in the early operative mortality rates from 22% with open surgery to 13% 
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using TEVAR (12). The overall all-cause mortality of 11.8% is reported in our series to date 
noting that six of our patients were lost to follow up (the regional birth and deaths registry did not 
record deaths in these 6 patients). Follow up is poor in post trauma patients. A local retrospective 
study by Pillai et.al, reported 42 survivors after TEVAR, with 19 follow-up CT scans available at 
6 months, 6 at 1 year and 2 at 2 years (24). 
The secondary end points in this review were the incidence of nonfatal adverse events related to 
the device, procedure, and re-intervention rates. Delivery and deployment was successful in 94.1% 
of cases, lower than the 100% technical success reported in the RESCUE trial (13). One patient 
had bird-beaking after deployment and one had a type I endo-leak managed with a left SCA plug. 
Forty- four percent (15/34) of patients had systemic and procedure related adverse events, a very 
high rate compared to that quoted in the literature (13,17). Six of the fifteen patients had 
pneumonia which was managed medically. The incidence of postoperative atelectasis and 
pneumonia in patients undergoing non-cavitatory surgery is reported to be 1% (25) but Antonelli 
et al. (26) documented 33% of trauma patients developed early onset pneumonia. Patients’ HIV 
status did not seem to influence these septic complications. Only one patient who was HIV 
positive in our series had pneumonia. All three patients with HIV in our series were on treatment 
(HAART). The benefit of antiretroviral therapy in HIV positive patients cannot be 
overemphasized. 
Partial or complete coverage of the left subclavian artery was documented in 47.0% (16/34) of our 
patients. None of these patients developed significant arm ischemia. One patient developed non- 
disabling left arm claudication and was managed expectantly. This result is in keeping with reports 
of 41% (24), 58% (13) and 61% (25) of intentional left subclavian artery coverage. There was no 
reported paraplegia in our patients post TEVAR, which is in keeping with low paraplegia 
Page | 29 
rates reported in the RESCUE trial. Demetriades et.al also reported a significant reduction in spinal 
cord injury from 8.7% with open surgery to 1.6% using TEVAR (12) 
The Society for Vascular Surgery (SVS) 2011 guidelines suggests expectant management with 
serial imaging for type I injuries, while types II to IV should be repaired (19). Only one patient 
(2.9%) with grade 1 aortic injury had TEVAR at our institution. A 23year old male with 
transthoracic GSW and a grade I aortic dissection of the descending thoracic aorta on CTA 
imaging. The decision was made by the operating vascular surgeon to perform a TEVAR. An 
intimal flap was identified with the use of intravascular ultrasound (IVUS). The RESCUE trial on 
the other hand selected 18% of patients with grade 1 aortic injuries for TEVAR (13). Lee et al. (19) 
reported that 21% of BTAI patients with minimal aortic injuries undergo TEVAR despite these 
clinical practice guidelines. 
Patients who had penetrating trauma, in our series, had more favourable results with no deaths 
reported. This is probably due to natural selection as these patients were younger, had low ISS 
scores and lower grades of aortic injuries associated with penetrating trauma. The time to TEVAR 
in this group of patients was longer, 13.5 days (range 4-67 days). Pacini et al. evaluated the timing 
of aortic repair and found improved survival among patients undergoing delayed repair (27). 
The limitations of this study include its retrospective design, the period of follow-up to date and 
loss of follow up. Missing data is also a major issue. 
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Chapter Five 
5.0 Conclusion and Recommendations 
TEVAR after TAI is associated with significantly lower procedural and post-operative mortality. 
The 30 day and overall mortality after TEVAR in our unit, despite resource constraints in an 
African setting, is comparable to international standards. The morbidity associated with TEVAR 
is higher in our institution mostly due to pulmonary complications. Even though our sample size 
for PTAI was very small and no conclusion can be drawn from this, TEVAR has low peri- 
procedural adverse events and is safe in selected patients. From this audit, we recommend TEVAR 
for both blunt and penetrating thoracic aortic injury. 
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Appendices 
Appendix A: Study Protocol 
Title: 
OUTCOMES AFTER THORACIC ENDOVASCULAR ANEURYSM REPAIR (TEVAR) IN 
PATIENTS WITH TRAUMATIC THORACIC AORTIC INJURIES (TTAI) - A single centre 
retrospective review 
BACKGROUND 
Blunt traumatic thoracic aortic injury (BTAI) caused by motor vehicle accident and blunt thoracic 
trauma is a surgical emergency with high mortality rates. Most patients do not survive long enough 
to reach the hospital. Two main treatment options for BTAI are open surgery and thoracic 
endovascular repair (TEVAR). Penetrating thoracic aortic injuries have a higher mortality than 
blunt trauma, with patients reaching the hospital in extremes. Most will require early intervention 
with a mortality as high as 80%. TEVAR has been accepted as the standard of care for thoracic 
aortic injuries (TAI) at many centers, primarily due to the convincing evidence of lower mortality 
and morbidity in comparison to open surgery (1)(2)(3)(4)(5)(6). The RESCUE trial was a prospective, 
non-randomized, multi-centre device trial that enrolled 50 patients with BTAI and reported one 
year follow-up data. Major procedural and long-term device complications were infrequent, and 
no patients required aortic re-intervention or had neurologic complications. Overall mortality at 30 
days and 1 year was 8 and 12 %, respectively; two deaths (4 %) were adjudicated as aortic-related 
7. 
TEVAR was only adopted in Groote Schuur Hospital (GSH) in 2009. 
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AIM 
The aim of this study is to evaluate the outcomes (early and intermediate) of TEVAR after TTAI 
(both blunt and penetrating), and to compare to international standards 
METHODS 
Working hypothesis and study objectives: 
Our hypothesis is that TEVAR after TAI is associated with significantly lower procedural and post- 
operative morbidity and mortality. We postulated that the 30-day mortality after TEVAR will be 
comparable to international standards. 
The study specific objectives are to look at the outcomes after TEVAR in patients with TTAI 
Types of outcome measures 
➢ Primary outcomes
o 30 day and overall mortality
➢ Secondary outcomes
o Procedure related (endo-leak, pseudo-aneurysm formation, paraplegia,
cerebrovascular accident, recurrent laryngeal nerve injury, acute renal failure,
conversion to open repair, pulmonary complications)
o Device related (stent configuration and wall apposition-arch, stent fracture, stent
migration, endo-leak; stent-graft sepsis);
o Reintervention rates
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Study design 
Single center Retrospective study in the Vascular Unit, Groote Schuur Hospital 
Selection of patients and data collection 
All the endovascular repairs of the TAI performed at our institution between January 2009 and 
December 2015 will be reviewed. Data will be reviewed from trauma registry, vascular registry 
and theatre registry. 
The medical records of the patients will be identified and reviewed with respect to 
 Baseline demographics, mechanism of injury, haemodynamic status of the patient, Glasgow
Coma Scale(GCS), concurrent injuries with assessment of the Injury Severity Score (ISS),
time to surgery
 Operative variables including the proximal landing zone, left subclavian artery status,
access vessels, technical success
 Imaging studies including CXR (erect AP film) for widening of mediastinum (>8cm), CT
scan and intraoperative angiogram for anatomical grading of injuries, arch anomalies, arch
configuration/type.
Post-operative events and complications will be recorded. 
 Procedure-related (endo-leak, pseudo-aneurysm formation, paraplegia, cerebrovascular
accident, recurrent laryngeal nerve injury, acute renal failure, conversion to open repair,
pulmonary complications)
 Device-related (stent configuration and wall apposition-arch, stent fracture, stent migration,
endoleak; stentgraft sepsis)
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Any readmissions, reoperations and mortality will also be audited. 
Postoperative CT scans will be reviewed and complications on follow up will also be audited 
Inclusion Criteria 
➢ Patients with traumatic aortic injury confirmed on CT scan on admission who were
treated with TEVAR
➢ >18 years




The base proportion used is the international post-operative outcome (30-day and overall mortality 
of 8 and 12% respectively). Standard statistical systems will be utilized to analyze accumulated 
data. 
Risks and benefits to patients 
There will be no risks involved 
We believe that this study could produce data and stimulate further research that may be of real 
benefit to patients including long term outcomes, durability of stent grafts, and the use of stent 
grafts in the younger population, CT angiography surveillance and exposure to radiation. 
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Data Safety and Reimbursement 
All patients’ names as well as their folder numbers will be removed from the data stream. The 
study adheres to the Declaration of the Helsinki 2013. There will be no reimbursement. 
Timeline /Schedule 
Time period 
July - October 2016 Literature review 
November- January 2017 Data collection 
February- April 2017 Results and write up 
May 2017 Submission of 1st draft 
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Appendix C: Data collection sheet 
Patient Number: 
Demographics 
Gender: male female: 
Age:   
Comorbidities: 
Medications: 
HIV: unknown  positive  negative   
HAART: yes  no   
Smoker: yes  no   
Previous vascular surgery: yes  no if yes 
Initial assessment 
GCS:   
Intubated: yes, at scene yes, in hospital no 
SBP: Pulse: 
Ph: Lactate: Creatinine: hb: 
Injury circumstances 
Date of injury: / /  
Mechanism of injury: blunt:  penetrating: 
Circumstances: MVA  Fall motorcycle Stab GSW other 
Restraints: yes  no if yes type 
ISS:   
Imaging 
CXR: widened mediastinum   yes no 
CXR Index:   
Anatomical classification: grade I  grade II grade III grade IV 
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Arch type: type I  type 2 type 3 
Arch anomalies:   
Intra- operative data 
Day of TEVAR:      /   /   
ASA:   
Access vessels:   
Device size:   
Landing zone:   
LSCA covered: yes  no 
LSCA plugged: yes no   
Hybrid procedure: yes  no if yes additional vascular procedure 
Heparin used: yes  no   
Length of surgery:   
Other surgery done same setting: 
Technical success: yes  no   
Post-op 
ICU stay:   
Hospital stay:   
Mortality 
30-day: yes  no
Cause of mortality: 
Overall: yes  no  
Cause of mortality: 
Complications 
Procedure related: 
Pneumonia   
Renal failure  Dialysis 
MI  VTE UTI Bacteraemia Wound complications 
Paraplegia level 
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Other:   
Stent graft related: 
Endo-leak 
Endo-tension 
Other:   
Re-intervention:   
Follow-up imaging 
At 1 month: 
At 6 months: 
At 1 year: 
Yearly after: 
Late complications: 
Follow up lost: yes  no 
If yes after how long months 
